Navigation Links
Wyeth to Present at the Credit Suisse Healthcare Conference
Date:11/10/2008

MADISON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) announced today that it will present at the Credit Suisse Healthcare Conference on Wednesday, November 12, 2008 at 11:30 a.m. Eastern Time. Presenting for Wyeth will be Michael Kamarck, Ph.D., Executive Vice President, Technical Operations and Product Supply, Wyeth Pharmaceuticals.

Wyeth's presentation will be webcast live for investors at http://www.wyeth.com and available for replay following the conference.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. The Senior Citizens Leagues Comments on U.S. Supreme Court Case Wyeth v. Levine
2. Wyeth v. Levine: Preemption and The Facts
3. Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
4. Wyeth Selected for 11th Consecutive Year as One of Working Mother Magazines 100 Best Companies for Working Mothers
5. Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
6. Wyeth to Present at the Goldman Sachs Annual Global Healthcare Conference
7. Wyeths Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
8. Wyeth to Present at the Morgan Stanley Global Healthcare Unplugged Conference
9. Wyeth Holds Annual Meeting of Stockholders
10. Wyeth to Expand State-of-the-Art Nutritional Manufacturing Facility in Singapore
11. Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...bbits implanted with new cells regained sexual fun... (HealthDay News) -- Researchers were able to rest...s by growing new penile tissue in the lab and impl...n application is a ways off, researchers say the t...ctile dysfunction in men. , "We were able to sh...
(Date:11/9/2009)..., SHENZHEN, China, Nov. 9 /PRNewswire-FirstCall/...al.com , announced today that Novartis, a US$41 bi...ng an 85% stake in HTDS, H1N1 Vaccine partner, Zhe...S$125 million. Novartis of Switzerland will begin ...aims: the company will dramatically increase its i...
(Date:11/9/2009)... Tomorrow may be too late w... condition, according to TOPS Club, Inc. (Take Off...rt organization. , (Vocus...n it comes to preventing or improving a diabetes c...ounds Sensibly), the nonprofit weight-loss support...
(Date:11/9/2009)... New study highlights posit...th , Rosemont, IL (Vocus)...ase and bone health decreases. Recent research has...m supplements to help prevent these issues. Howeve...issue of Sports Health: A Multidisciplinary Appro...
(Date:11/9/2009)..., SANTA MONICA, Calif., Nov. 9 A...ndation joined philosophy on Saturday to rai...support services throughout California by building...lters. Enough kits were created to give one to ea...ed in one of Los Angeles County,s domestic violenc...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3
...Ageing populations are an increasing issue for the... sixty is growing plus there has been a rise in ol...ose living with children or relatives. A new study...ness of older people and how it varies within Euro...
...hind-the-counter, dispensing would bypass doctors ... 14 (HealthDay News) -- During a day-long public h... to be sold by pharmacists without a prescription,...est groups. , But at the day,s end, the FDA offici...
... FRANCISCO, Nov. 14 Some 225 healthcare,organizat...ived recognition,for their outstanding websites at... during the Eleventh Annual Healthcare Internet Co...healthcare and,the Internet judged the entries. T...
...NE, Pa., Nov. 14 Escalon Medical Corp.,(Nasdaq: ...t quarter ended,September 30, 2007. For the first...revenue,of $6,893,271, a 4% decrease from the $7,1...ich decreased 3% and 2%,respectively, compared wit...
...COUVER, Nov. 14 /PRNewswire-FirstCall/ - Dragon Ph...P) today announced that it has entered an,agreemen...PO business which,accounted for less than 3% of Dr...h potential, if not downward trend, during,the nex...
...LEY, N.J., Nov. 14 Roche announced today,that the...ved MIRCERA,(methoxy polyethylene glycol-epoetin b...hronic renal failure (CRF) in adults, including pa...s-stimulating agent (ESA) to provide correction of...
Other Medicine News:Health News:Living arrangements, health and well-being: A European perspective 2Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 2Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 3Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 4Health News:Epilepsy.com Wins Silver for Best Patient Care/Disease Management Website at the 2007 eHealthcare Leadership Awards - Honored at Healthcare Internet Conference in Las Vegas 2Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 2Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 3Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 4Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 5Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 6Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 7Health News:Dragon Sells EPO Business; Focus on Antibiotic Core Business 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 3
(Date:11/9/2009)...Nov. 9 ARmark Authentication Techn...n alliance in the development and introduction of ...on technology that incorporates microscopic covert...gs of solid oral dosage forms (SODFs) to prevent c...usive rights to market ARmark,s micro-tags for tab...
(Date:11/9/2009)...SCO, Calif., Nov. 9 Anes... November 5, 2009, it received a letter from The N... Nasdaq Hearing Panel has granted Anesiva,s reques...t subject to the condition that Anesiva shall have...posed merger (the "Merger") contemplated by the Ag...
(Date:11/9/2009)..., Nov. 9 Caliper Life Sc...of tools and services for drug discovery and life ...r Discovery Alliances and Services (CDAS) unit has...llion under its contract with the Environmental Pr...ing program. This new task order increases the cu...
Breaking Medicine Technology:ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Caliper Awarded New Task Order for EPA ToxCast Program 2Caliper Awarded New Task Order for EPA ToxCast Program 3Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 1Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 2Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 3Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 1Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 2Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 3Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 4VitaPath Genetics Raises 246M in Series A Round 56742 1VitaPath Genetics Raises 246M in Series A Round 56742 2
...RNewswire-FirstCall/ -- Auxilium,Pharmaceuticals, ...,Executive Officer and President, and Mr. Jim Fick... in the 2007 CEUT Emerging,Growth Opportunities Co...at the Mandarin Oriental Hotel in New York City. M...e Company and its product,pipeline at 4:30 PM East...
...uly 10, 2007 /CNW/ - Protox,Therapeutics Inc. (TSX... from its Phase 1 clinical trial evaluating ,PRX30...ancer,following radiation failure. The trial resu...ed and shows promising signs,of therapeutic activi... , ,"The completion of the PRX302 Phase 1 tri...
Other Medicine Technology:Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging,Growth Opportunities Conference 2Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging,Growth Opportunities Conference 3Protox Announces Positive Clinical Data from Prostate Cancer Study 2Protox Announces Positive Clinical Data from Prostate Cancer Study 3Protox Announces Positive Clinical Data from Prostate Cancer Study 4Protox Announces Positive Clinical Data from Prostate Cancer Study 5
...is a purified and lyophilized bovine dermal collag...s lightly cross-linked, sterile, non-pyrogenic, an...erent property of collagen, is largely dependent o... helical structure of native collagen is preserved...
...able microhematocrit determinations. Although the ... than most competitive 6 tube centrifuges. The hig...cluded reader is adjustable, allowing accurate rea...ter operation than many similiar units, the Micros...
... engineering and design specifications, Smith & Ne...eamless integration with existing inventories and ... procedures (AO method). However, the TC-100 syste... range of components, increased cost-effectiveness...
... most technically demanding specialties within ort...ffers the highly specialized surgeon a complete an...pelvis and acetabulum. , ,Joel Matta, MD, world r...ner of this system. The system features specific r...
Medicine Products: